Lincomycin is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Xgen Pharmaceuticals Djb, Inc.. The primary component is Lincomycin Hydrochloride.
| Product ID | 39822-0353_092c8514-aca2-410e-901f-bfa21a622850 |
| NDC | 39822-0353 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lincomycin |
| Generic Name | Lincomycin Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Marketing Start Date | 2015-07-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA201746 |
| Labeler Name | XGen Pharmaceuticals DJB, Inc. |
| Substance Name | LINCOMYCIN HYDROCHLORIDE |
| Active Ingredient Strength | 300 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2015-07-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA201746 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-07-05 |
| Ingredient | Strength |
|---|---|
| LINCOMYCIN HYDROCHLORIDE | 300 mg/mL |
| SPL SET ID: | 61f4851d-d919-400d-912a-05eb9dca11d4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9901 | LINCOMYCIN | lincomycin hydrochloride |
| 39822-0350 | Lincomycin | lincomycin hydrochloride |
| 39822-0353 | Lincomycin | lincomycin hydrochloride |
| 42571-374 | Lincomycin | Lincomycin |
| 50090-4533 | Lincomycin | lincomycin hydrochloride |
| 52584-353 | LINCOMYCIN | lincomycin hydrochloride |
| 70436-034 | lincomycin | lincomycin |
| 70436-035 | lincomycin | lincomycin |
| 70625-113 | Lincomycin | lincomycin |
| 0009-0555 | Lincocin | lincomycin hydrochloride |
| 68083-478 | lincomycin hydrochloride | lincomycin hydrochloride |
| 68083-479 | Lincomycin hydrochloride | lincomycin hydrochloride |